Israel Defense Force   Report issue

Government Phase 3 Phase 4
Founded: HaKirya Israel (1948)

Organization Overview

First Clinical Trial
2002
NCT00237016
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Head of Motion Sickness and Human Performance Laboratory, Principal Investigator | Medical Corps, Israel Defense Force